Cargando…
Auranofin, a thioredoxin reductase inhibitor, causes platelet death through calcium overload
Platelets are central to normal hemostasis and must be tightly controlled to prevent thrombosis. However, drug treatments that also affect platelets could lead to unwanted side effects on hemostasis or thrombosis. In this study, the effect of auranofin on platelets was tested. Auranofin, a gold-base...
Autor principal: | Harper, Matthew T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406207/ https://www.ncbi.nlm.nih.gov/pubmed/29194002 http://dx.doi.org/10.1080/09537104.2017.1378809 |
Ejemplares similares
-
Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
por: Wang, Hui, et al.
Publicado: (2017) -
Auranofin Inhibition of Thioredoxin Reductase in a Preclinical Model of Small Cell Lung Cancer
por: Johnson, Spenser S., et al.
Publicado: (2023) -
Enhancement of Auranofin-Induced Apoptosis in MCF-7 Human Breast Cells by Selenocystine, a Synergistic Inhibitor of Thioredoxin Reductase
por: Liu, Chaoran, et al.
Publicado: (2013) -
Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells
por: Seo, Min Ji, et al.
Publicado: (2023) -
Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase
por: Ma, Christopher I., et al.
Publicado: (2021)